Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. Breast milk can make the difference between life and death for many babies around the world, particularly those born prematurely, but getting milk to babies in need is a challenge.
    Published: May 2023
  2. Women make up 70 percent of the health care workforce but continue to be led by men. PATH’s Levis Nderitu, Director of Global Diversity, Equity, and Inclusion, explains how PATH works to increase diversity in its leadership and staff
    Published: May 2023
  3. Malawi is likely to sign the African Medicines Agency (AMA) Treaty soon. PATH’s Johnpaul Omollo talks about how the AMA will help harmonize regulatory systems and improve access to quality medical products in Africa.
    Published: May 2023
  4. Malawi’s first-ever national typhoid vaccination campaign begins this month. PATH’s Esau Mkisi explains how PATH and the Ministry of Health are working together to make this campaign a success.
    Published: April 2023

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

971 Item s
971 Item s
    Date
    From
    To
  1. PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  2. Published: October 2024
    Announcement
  3. The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
  4. Published: October 2024
    Announcement
  5. Published: October 2024
    Press Release